Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane deriv

Details Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane deriv Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane deriv

1995-05-26

1996-11-12

Rotman, Alan L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546112, 546125, 546133, 546137, 548452, C07D45102, A61K 3146

Patent

active

055740430

ABSTRACT:
The present invention relates to therapeutically active azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.

REFERENCES:
patent: 5041455 (1991-08-01), Sauerberg et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
patent: 5418240 (1995-05-01), Sauerberg et al.

Affiliated with

Also associated with

Rating

Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane deriv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane deriv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane deriv will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-562834